Product Name:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

CAS:915087-32-0
Molecular Formula:C12H14FN3O
Purity:95%+
Catalog Number:CM329948
Molecular Weight:235.26

Packing Unit Available Stock Price($) Quantity
CM329948-100mg in stock řijř
CM329948-250mg in stock Žijř
CM329948-1g in stock ijǎǟ
CM329948-5g 1-2 Weeks řƴţř

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:915087-32-0
Molecular Formula:C12H14FN3O
Melting Point:-
Smiles Code:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F
Density:
Catalog Number:CM329948
Molecular Weight:235.26
Boiling Point:
MDL No:
Storage:

Column Infos

Enzalutamide
Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.